Article discusses results demonstrating parenteral support (PS) reduction ranging from 12 to 37% in ongoing proof-of-concept study of crofelemer in pediatric patients with intestinal failureAssociated ...
Alison Wagonfeld will report to CEO Jensen Huang as marketing rises in importance at the AI chip maker. Beijing worries the $2.5 billion acquisition of startup Manus will encourage more entrepreneurs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback